Aveanna Healthcare Holdings Inc

Aktienanalyse zu Aveanna Healthcare Holdings Inc (AVAH)

$12.340

-0.292 (-2.37%)Zum Schluss

Loading chart…
Hoch
12.720
Eröffnung
12.650
Volumengewichteter Durchschnittskurs
12.44
Volumen
2.33M
Marktkap.
492.49M
Tief
12.250
Umsatz
28.94M
EV/EBITDA, TTM
10.42

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

ir.aveanna.com

KI-Analyse of Aveanna Healthcare Holdings Inc (AVAH)

Halten

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Aveanna Healthcare Holdings Inc (AVAH) beträgt 13.32, verglichen mit dem 5-Jahres-Durchschnitt von 37.40.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
37.40
Aktuelles P/E
13.32
Überbewertet
140.10
Unterbewertet
-65.29

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
11.87
Aktuelles EV/EBITDA
10.42
Überbewertet
13.41
Unterbewertet
10.32

Erwartetes KUV

Stark überbewertet
5J-Durchschnitt P/S
0.41
Aktuelles P/S
0.93
Überbewertet
0.65
Unterbewertet
0.17

Alphio-AI-Kursszenarien für AVAH

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%AVAH

$6.77

Szenariopreis

B

Basis

Basis · 50%AVAH

$6.66

Szenariopreis

B

Bärisch

Bärisch · 25%AVAH

$6.42

Szenariopreis

Whales, die AVAH halten

B

Braidwell LP

+ HältAVAH

+15.28%

3-Monats-Rendite

J

Jaunty Global Limited

+ HältAVAH

-1.42%

3-Monats-Rendite

Event-Zeitleiste

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

News

AVAH FAQ – beantwortet von Alphio AI

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln